Dx | Edu | Beh | CBT | Mot | Sup | MCo | Oth | |
---|---|---|---|---|---|---|---|---|
Medication | RA | 3+/3− | 1+/1− | 1+ | 2+ | 1~ | ||
SLE | 1+ | 1− | ||||||
Psoriasis | 1+ | |||||||
OP | 1~/1− | |||||||
Total | 4+/3− | 1+/2− | 1+ | 3+ | 2~/1− | |||
Exercise | OA | 2+/4− | 3− | 1+ | 2+/1− | 3+/2− | ||
RA | 2+ | 3+/2− | 3~ | |||||
Mixed | 1+ | 1+ | ||||||
CBP | 1~ | 1+ | 1+ | |||||
Total | 5+/4− | 4+/1~/5− | 2+ | 2+/1− | 1+/3~ | 3+/2− | ||
Visits | RA | 3+ | ||||||
SLE | ||||||||
Total | 3+ |
Beh, behavioural interventions; CBP, chronic back pain; CBT, cognitive–behavioural therapy; Dx, diagnosis; Edu, educational interventions; MCo, multicomponent interventions; Mot, motivational interventions; OA, osteoarthritis; OP, osteoporosis; Oth, other interventions; PICO, Population; Intervention/factor; Comparator; Outcome; RA, rheumatoid arthritis; Sup, supervised exercise; SLE, systemic lupus erythematosus.
The numbers indicate the count of the studies. Numbers followed with a ‘+’ indicate significant increase in adherent behaviour, ‘−’ means no increase in adherent behaviour and ‘~’ means unclear results.